86results about "Pancreatin" patented technology

The present invention relates to peptides which exhibit potent anti-retroviral activity. The peptides of the invention comprise DP178 (SEQ ID:1) peptide corresponding to amino acids 638 to 673 of the HIV-1LAI gp41 protein, and fragments, analogs and homologs of DP178. The invention further relates to the uses of such peptides as inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells.

A method for treating a Parkinson's patient with digestive/pancreatic enzymes involves administering an effective amount of digestive/pancreatic enzymes to an individual having the disorder in order to improve a symptom of the disorder. In addition, a method is provided for determining whether an individual has, or may develop, Parkinson's disease or related dysautonomic disorders and for determining whether an individual will benefit from the administration of pancreatic/digestive enzymes to treat the dysautonomic disorder.

Methods for preparing products containing moisture-sensitive materials, including biological materials such as proteins, peptides or live cells, comprising at least the steps: (i) providing a coating liquid comprising at least one active, a sugar polymer and a water soluble/miscible solvent; (ii) providing a quantity of microparticles comprising at least water soluble gel forming solid particles; (iii) fluidizing said quantity of microparticles within a processing chamber of a of a suitable apparatus to form a fluidized bed of said microparticles; (iv) spraying said coating liquid onto said fluidized bed from beneath the fluidized bed to coat said microparticles therewith under saturated moisture conditions; and (vi) allowing coated microparticles to dry, are described. Also described are compositions and uses.

The present invention relates to α-amylase variants that are stabilized to dimerization and/or multimerization, in particular at elevated temperatures or high pH, by point mutagenesis of positively polarized or charged or neutral surface amino acids to give more negatively polarized or charged amino acids. The invention further relates to methods of increasing the stability of an α-amylase to dimerization and/or multimerization brought about by electrostatic interactions whereby at least one amino acid residue on the surface of the starting molecule, which makes a neutral or positively polar or charged contribution to the electrostatic potential of said molecule, is replaced with a more negatively polar or negatively charged amino acid residue. The α-amylase variants obtained thereby exhibit better stability to influences of the solvent, increased processivity, and are suited for numerous industrial areas of use, in particular as active ingredients in detergents and cleansers.

The present invention provides a composition comprising an enzyme, e.g. oxidase enzyme, a source of zinc and/or ammonium ions and a source of lactate ions. The compositions are typically sterilised by exposing the compositions to sterilising radiation, e.g. gamma radiation. The incorporation of a source of zinc and/or ammonium ions and a source of lactate ions, e.g. zinc L-lactate, in the enzyme-containing composition results in an improvement in enzyme activity post-sterilisation. The presence of a source of zinc and/or ammonium ions and a source of lactate ions in the composition therefore has a protective effect on the enzyme during exposure to sterilising radiation so that good recovery of enzyme activity can be obtained.

The invention relates to a method for reducing the viral and microbial content of biological extracts which contain solids. It is provided that the method comprises the steps

• (a) provision of the biological extract which contains solids, comprising a biologically active substance, selected from enzymes, proteins and peptides, or a mixture of such substances; and
• (b) subjecting the biological extract provided in step (a) to a high-pressure treatment;

wherein the biological activity of the biological extract which contains solids after the high-pressure treatment is at least 50% of the biological activity of the biological extract which contains solids before the high-pressure treatment.

The present invention provides a method for directed selective solid-phase culturing of stable microbial mixed populations for the continuous preparation of defined enzyme and metabolite mixtures, enzyme and metabolite materials obtained by such method and suitable devices therefore.

A drift layer has a thickness direction throughout which a current flows and has an impurity concentration N_1d for a first conductivity type. A body region is provided on a portion of the drift layer, has a channel to be switched by a gate electrode, has an impurity concentration N_1b for the first conductivity type, and has an impurity concentration N_2b for the second conductivity type greater than the impurity concentration N_1b. A JFET region is disposed adjacent to the body region on the drift layer, has an impurity concentration N_1j for the first conductivity type, and has an impurity concentration N_2j for the second conductivity type smaller than the impurity concentration N_1j. N_1j−N_2j>N_1d and N_2j<N_2b are satisfied.

The invention discloses a preparation method of water-soluble yellow fluorescent carbon quantum dots. The preparation method includes the steps: S1 uniformly mixing pancreatic enzymes, ethylenediamine and ultra-pure water to obtain mixed liquid, and performing hydrothermal reaction on the mixed liquid to prepare reaction liquid; S2 performing centrifugation, filtration, dialysis and evaporation to prepare the water-soluble yellow fluorescent carbon quantum dots. The mass volume ratio of the pancreatic enzymes, the ethylenediamine to the ultra-pure water is 1.5g: 1mL: 9mL. The quantum dots take pancreatic enzymes and the ethylenediamine as raw materials which are natural, free from toxicity, low in cost and easy to obtain, the preparation method is simple, rapid and efficient by a hydrothermal method, and the yield of the quantum dots is high.

The present invention relates to a method for isolating mesenchymal stem cells from placental vessels and used digestive enzyme compositions. The method comprises the following steps: the placenta issterilized with alcohol; Dissecting placental blood vessels from the placenta; Cut into pieces, wash with PBS, filter the residual blood stains to obtain placental vascular tissue; Adding mixed enzymesolution to digest; End digestion, filter and collect tissue fluid; The placental mesenchymal stem cells (P0) were obtained by centrifugation and cultured with DMEM-F12 basal medium was resuspended and the number and viability of nucleated cells were counted. The obtained cells are cryopreserved with cryopreservation protection solution so as to be re-cultured before use, or the passages and/or the mesenchymal stem cells are continued to be subjected to cell identification and/or detection, cryopreservation, library establishment and the like. The method of the invention can effectively improve the efficiency of isolating mesenchymal stem cells from the blood vessels of the placenta.

Disclosed is a method for promoting production of biogas using pancreatin in an anaerobic digestion process. In addition, disclosed are a composition for improving hydrolysis efficiency or promoting production of biogas, which includes pancreatin as an active ingredient, and a method for promoting (or increasing) production of biogas from organic manure of livestock using the same. The composition for improving hydrolysis efficiency or for promoting production of biogas in an anaerobic digestion process for treatment of organic waste, includes pancreatin as an active ingredient. The organic waste is livestock manure, and the composition has optimum activity at pH 7.0 to pH 8.0. The composition further includes a microorganism with excellent degradability of degradation resistant organic compounds.

An effective liquid preparation achieves high bioavailability (BA) of physiologically active peptides or proteins, including ghrelins, that are administered as drugs. Also provided is a method for improving the BA of physiologically active peptides or proteins, including ghrelins, that are subcutaneously injected in aqueous solutions. The liquid preparation contains: a physiologically active peptide or protein, such as ghrelins, as an active ingredient; an acid solution including one or a combination of two or more selected form the group consisting of acetic acid, lactic acid, phosphoric acid, glycine, citric acid, hydrochloric acid, propionic acid, butyric acid, benzoic acid and salts thereof; an alcohol; and a polar organic liquid including one or a combination of two or more selected from the group consisting of N-methyl-2-pyrrolidone, dimethylformamide, dimethylsulfoxide and methylparaben.

The invention provides a method for preparing high-activity pancreatin. The method comprises the following steps of: by adopting porcine pancreas or the rest pancreatic slag generated by extracting insulin through neutral ethanol as a raw material; adding 2% of calcium chloride solution for activating, adding moderate NaCl, NH4Cl, sucrose, starch, glycerinum and tween 80; adjusting pH (Potential of Hydrogen) to 5.5 to 7.0 through 4mol/Lof Na2HPO4; activating for 6 hours at 30 DEG C; dividing size and filtering to remove residues; standing for cooling to reach 4 to 6 DEG C; precipitating through PEG (Polyethylene Glycol)-6000; degreasing through acetone; and drying to obtain the pancreatin. According to the method, the yield of the pancreatin is increased by 16% under the pancreatin extraction environment set in the experiment, and the activity of three enzymes is obviously improved, wherein the activity of trypsin is increased by 13%, the activity of amylopsin is increased by 26%, and the activity of pancreatic lipase is increased by 43%; the activity of the pancreatic lipase, which is easily damaged, is greatly improved.

The invention relates to the technical field of cell isolated culture, particularly a digestive enzyme composition and application thereof, and an isolated culture method of umbilical epithelial cells. The digestive enzyme composition comprises hyaluronidase, collagenase VIII and pancreatin. The umbilical epithelial cell primary isolation adopts the hyaluronidase, collagenase VIII and pancreatin for combined digestion. The digestive enzyme composition has the advantages of mild properties, low cell trauma and high enzymolysis rate and greatly enhances the epithelial cell isolation efficiency.

The invention provides a method for preparing pancreatic enzyme powder. The method comprises the following steps of (1) collecting pancreas; (2) preserving the pancreas at a low temperature; (3) carrying out thawing, impurity removing and mincing; (4) extracting the pancreas so as to obtain pancreas slurry, and filtering by utilizing a frame filter press, so as to obtain an extracting solution; (5) adding ethanol into the extracting solution, standing, filtering by utilizing the frame filter press, and collecting a filter cake; (6) washing and centrifuging the filter cake to obtain sediments; (7) drying the sediments in vacuum and crushing, so as to obtain the pancreatic enzyme powder. According to the method, the bovine pancreatic enzyme powder accordant with a Mohammedanism rule is provided, and the market blank is made up; a method for preparing the industrial pancreatic enzyme powder by virtue of pig pancreas is technically improved. The method has the advantages that the production cost is low, the pollution to a final product and the environment is avoided, and the production security is greatly improved; the operation process is simplified, the consumed time is short, the time for preparing each batch of product only lasts for 45-48 hours, and the method is easy to industrialize. The product prepared by utilizing the method has the advantages that three enzyme activities are high and the yield reaches 11.0%.

The present invention pertains to an enzyme preparation obtained from e-beam irradiated animal tissue, such as porcine pancreas. The present invention also pertains to methods for making such enzyme preparations, pharmaceutical compositions comprising such enzymes preparations, and methods for using such pharmaceutical compositions and enzyme preparations.

The invention relates to a Model Gut System (MGS) comprising a pancreatic phase consisting essentially of synthetic pancreatic juice comprising pancreatin and one or more suitable pancreatic diluent(s) at a pH from about 7 to about 9, preferably about 7.9 to about 8.2, and porcine bile.

The invention provides pancreatin and an enteric capsule thereof. An amino acid sequence of the pancreatin is shown in SEQIDNO:2 and the like; a particle in the pancreatin enteric capsule is composed of a pill core and a coating wrapped outside the pill core, wherein the pill core is composed of the pancreatin, cane sugar, dextrin and hydroxypropylated methylcellulose, and the coating is composed of polyacrylic resin, triethyl citrate and talcum powder.

The invention relates to a preparation method of pancreatin. The preparation method comprises following steps: pancreas is subjected to grounding, hydrogen peroxide is added so as to obtain a mixture,wherein the mass ratio of hydrogen peroxide in the mixture is controlled to be 0.1 to 2%; the mixture is stirred for 1 to 8h, catalase is added for 0.5 to 2h of reaction, and degreasing, activating,deposition, and drying are carried out so as to obtain pancreatin. In the preparation method, hydrogen peroxide is capable of realizing full contact with virus in a relatively short time, so that virus inactivation is realized; the residual hydrogen peroxide is degraded by catalase into water and oxygen, so that no hydrogen peroxide is left in pancreatin, the drug virus safety is improved greatly,and the obtained pancreatin product is capable of satisfying the strict requirements of pharmacopeia and animal-sourced biochemical medicine standards of different states.